Interferon ( Interleukin 12 (IL-12) is a heterodimeric cytokine with many functions including induction of interferon (IFN)-␥ by natural killer (NK) cells and generation of T helper 1 (Th1) cells producing IFN-␥ (1). The role of IL-12 in promoting endogenous protective immune responses to viral infections, however, is only beginning to be understood (2, 3). Our studies of IL-12 administration during lymphocytic choriomeningitis virus (LCMV) infections of mice have demonstrated that high concentrations of the factor are detrimental to expansion of protective CD8 ϩ cytotoxic T lymphocytes (CTL) and synergize with endogenous immune responses to promote systemic toxicities (4, 5). These results suggest that, if endogenous IL-12 is to play a role in viral infections requiring CD8 ϩ T cell responses for defense, the levels of expression would have to be tightly regulated. Interestingly, HIV infections are also associated with protective CD8 ϩ CTL (6-9), and cells from HIV-infected individuals are inhibited in their ability to produce IL-12 (10, 11).Studies from this laboratory evaluating endogenous expression and function of IL-12 indicate that the factor is differentially regulated in contrasting viral infections of mice. Although early IL-12 protein expression is induced during murine cytomegalovirus (MCMV) infection (12) and results in NK cell , detectable levels of IL-12 and NK cell IFN-␥ production are not observed during LCMV infection (12). The presence of IL-12 inversely correlates with induction of CTL function; in contrast to MCMV, LCMV infections readily induce high levels of CD8 ϩ CTL activity. In addition, treatments with antibodies neutralizing IL-12 do not significantly modify the prominent late T cell CTL and IFN-␥ responses during LCMV infection (12). These results are in striking contrast to the demonstrated IL-12 dependency of T cell IFN-␥ responses during bacterial and parasitic infections (1-3, 15, 16). Taken together, the studies suggest that IL-12 responses are differentially regulated during particular viral infections, and that IL-12-induced effects under the conditions of viral infections are distinct from those observed during other challenges.One of the conditions distinguishing viral infections is early induction of systemic IFN-␣͞ production (17-19). The experiments presented here were undertaken to evaluate the effects of these factors on IL-12 and IFN-␥ expression. The results show that production of the cytokines is inhibited by IFN-␣͞. They demonstrate that IFN-␣͞ inhibition acts on expression in response to known exogenous inducers of IL-12 and is an endogenous component shaping cytokine expression during viral infections.